missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human VEGF 165 Protein
Click to view available options
Quantità:
1 mg
10 μg
50 μg
500 μg
Formulazione:
Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.
Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with trehalose.
Dimensione della confezione:
10µg
1mg
500µg
50µg
Descrizione
Measured in a cell proliferation assay using HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci. USA 87:1323. The ED50 for this effect is 1-6 ng/mL. The specific activity of recombinant human VEGF165 is approximately 1.7 x 103 U/μg, which is calibrated against recombinant human VEGF165 WHO Standard (NIBSC code: 02/286). Specific activity is for reference purposes only and is not routinely tested.
Specifica
Specifica
| Formulazione | Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. |
| ID gene (immissione) | 7422 |
| Peso molecolare | observed_molecular_weight: 20-22 kDa, under reducing conditions. 39-42 kDa, under non-reducing conditions. |
| Nome | VEGF 165 |
| Quantità | 50 μg |
| Sorgente | Spodoptera frugiperda,Sf 21 (baculovirus)-derived human VEGF protein Ala27-Arg191 |
| Requisiti di stoccaggio | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Forma strutturale | Disulfide-linked homodimer |
| Coniugato | Unconjugated |
| Recombinant | Recombinant |
| Vedi altri risultati |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto